Elliott Management Releases Presentation on Daikin Industries, Ltd.
LONDON, April 26, 2026 /PRNewswire/ -- Elliott Investment Management L.P. and Elliott…
Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
April 07, 2026 08:00 ET | Source: Valitor, Inc. BERKELEY, Calif., April 07,…
AiPPT.com Introduces Nano Banana 2 to Better Serve Growing Presentation Needs
SINGAPORE, March 23, 2026 /PRNewswire/ -- AiPPT.com announced an update to its built-in…
Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit
LEHI, Utah, March 2, 2026 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
Elliott Management Releases Presentation on Toyota Industries Corporation
Elliott does not intend to tender its shares into the Revised TOB…
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong…
The Shaw Prize Award Presentation Ceremony 2025: Continuing 22 Years of Legacy in Science and Innovation
HONG KONG, Oct. 21, 2025 /PRNewswire/ -- The Shaw Prize presented its…
Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET…
Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE)…
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety…
